AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 304.16B, AstraZeneca(AZN) trades at $195.94. The stock has a price-to-earnings ratio of 29.39 and currently yields dividends of 1.6%.
On 2026-03-31, AstraZeneca(AZN) stock moved within a range of $194.31 to $196.90. With shares now at $195.94, the stock is trading +0.8% above its intraday low and -0.5% below the session's peak.
Trading volume for AstraZeneca(AZN) stock has reached 1.17M, versus its average volume of 1.8M.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
AZN News
Regional expansion was probably the biggest driver of growth for the treatment, Chief executive of AstraZeneca’s rare-disease unit Alexion, Marc Dunoyer said. C...
AstraZeneca (AZN) announced the efzimfotase alfa Phase III clinical programme, designed to study a broad hypophosphatasia, HPP, patient population, demonstrated...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
81%
of 31 ratingsMore AZN News
Guggenheim Raises AstraZeneca Price Target Ahead of Q1 Earnings By Joel South Published Mar 30, 9:58AM EDT Quick Read AstraZeneca (AZN) reported FY2025 revenu...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
AstraZeneca reported that its antibody drug tozorakimab succeeded in two Phase 3 trials in chronic obstructive pulmonary disease (COPD), targeting a broad COPD...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) is running a new early-stage cancer trial called “A Modular Ope...
AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms...
(RTTNews) - Shares of AstraZeneca PLC (AZN) are gaining about 4 percent on Friday morning trading after the company announced positive high-level results from t...
Positive COPD Data Tozorakimab is a monoclonal antibody targeting interleukin-33 (IL-33), which inhibits the signalling of the reduced and oxidised forms of IL...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.